Shoshana Lipson, a patient advocate and founder of the “CGRP & Migraine Community ” on Facebook explains what she sees as the biggest takeaways from the migraine peer exchange that she participated in.
Transcript:
What were the biggest takeaways from the migraine peer exchange that you participated in?
So, I would say that the biggest takeaway that I have from the peer exchange today would be that there's hope on all sides. I think especially on the physician side but also from the employer side and the payer side. We're now dealing with a new situation because of this new frontier in migraine treatment and so it is just generating a lot of interest and a lot of hope on every side.
It was also highlighted to me that the situation is complex. Not only getting access to the medications but getting them improved by the insurance companies, bringing employers into the conversation as well, that it's not an easy process, and that each side doesn't necessarily know where the other side is at, so improving communications for all of these branches is huge.
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More